The National Healthcare Quality and Disparities Reports have moved to the new AHRQ Data Tools site. After June 30, 2022, this web page will no longer be available.

MaineChildren Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Children are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Achieved Benchmark or Better
Measure Population Estimate Benchmark Distance to Benchmark
Hospital inpatient stays involving opioid-related diagnoses per 100,000 population Age 1-24 52.4 102.9 Achieved: 49% better
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine Total 93.3 96.4 Achieved within: 3.2%
Children ages 19-35 months who received 1 or more doses of varicella vaccine Total 92.6 95.7 Achieved within: 3.3%
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine Total 87.1 90.6 Achieved within: 3.9%
Children ages 19-35 months who received 3 or more doses of polio vaccine Total 92.6 97.3 Achieved within: 4.8%
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine Total 90.9 96.4 Achieved within: 5.7%
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years Total 85.8 95.2 Achieved within: 9.9%
Measures That Are Close to Benchmark
Measure Population Estimate Benchmark Distance to Benchmark
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years Total 85.7 95.9 10.7%
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine Total 84.6 96.2 12.0%
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine Total 82.0 95.4 14.1%
Infants born in the calendar year who received breastfeeding exclusively through 3 months Total 52.9 63.6 16.8%
Measures That Are Far From Benchmark
Measure Population Estimate Benchmark Distance to Benchmark
Emergency department visits involving opioid-related diagnoses per 100,000 population Age 1-24 111.9 65.2 71.5%
Birth trauma - injury to neonate per 1,000 selected live births Total 8.0 2.8 182.3%
Measures With No Available Benchmark Information
Measure Population Estimate Benchmark Distance to Benchmark
Hospital admissions for short-term complications of diabetes per 100,000 population, children ages 6-17 Total 7.9
Hospital admissions for asthma per 100,000 population, children ages 2-17 Total 24.4